Wells Fargo Maintains Underweight on Colgate-Palmolive, Lowers Price Target to $92
Colgate's Sales Growth Potential Offset by Challenging Comps -- Market Talk
DBS Maintains Colgate-Palmolive(CL.US) With Hold Rating, Announces Target Price $104
Colgate-Palmolive: Hold Rating Amid Strong Performance and Limited Upside Potential
Colgate-Palmolive Facing Competitive Comparisons, Softer Organic Sales Growth - Analyst
BofA Securities Maintains Colgate-Palmolive(CL.US) With Buy Rating
Stocks on Sale: Colgate-Palmolive, DexCom, and Realty Income
This Colgate-Palmolive Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Colgate-Palmolive Shares Dip After Stifel Downgrades to 'Hold', Cuts PT
A Quick Look at Today's Ratings for Colgate-Palmolive(CL.US), With a Forecast Between $92 to $112
Colgate-Palmolive Is Maintained at Buy by TD Cowen
Colgate-Palmolive Price Target Cut to $110.00/Share From $115.00 by TD Cowen
Colgate-Palmolive Analyst Ratings
Evercore ISI Reaffirms Their Buy Rating on Colgate-Palmolive (CL)
Sell Recommendation for Colgate-Palmolive Amid Valuation Normalization and Growth Concerns
Stifel Downgrades Colgate-Palmolive to Hold From Buy, Adjusts Price Target to $101 From $105
Colgate-Palmolive: Hold Rating Amid Growth Challenges and Competitive Pressures
Nasdaq Surges To Fresh Highs As Nvidia, Meta And Amazon Surge: Fear Index Remains In 'Greed' Zone
J.P. Morgan Maintains Colgate-Palmolive(CL.US) With Buy Rating, Cuts Target Price to $109
Morgan Stanley Maintains Colgate-Palmolive(CL.US) With Buy Rating, Maintains Target Price $111